Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Post S et al. - In a study to assess whether expression of topoisomerase I (Topo I) and thymidylate synthase (TS) helps predict treatment response in pts undergoing irinotecan and capecitabine-based chemoradiation, it was reported that Topo I expression in rectal tumour mucosa might serve as a predictor of response to neoadjuvant irinotecan-based chemoradiation, and might be a factor contributing to development of individualized treatment.

Methods

Results

Related Articles

Obesity linked to specific cancers
Internet Source, 11/05/09    Relevance Score: 69%%

Plasma enterolactone and risk of colon and rectal cancer in a case–cohort study of Danish men and women
Cancer Causes and Control, 10/28/09    Relevance Score: 69%%

Childhood Cancer Survivors Experience Suicidal Thoughts Decades After Diagnosis
ScienceDaily, 10/27/09    Relevance Score: 69%%

American Cancer Society Stands by Cancer Screening Guidelines
MedLinePlus, 10/23/09    Relevance Score: 69%%

New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09    Relevance Score: 69%%

Today in GI Oncology...keeping you current

Sorafenib in patients with advanced biliary tract carcinoma: A phase II trial
British Journal of Cancer, 11/29/09

A new staging system is more discriminant than conventional staging systems for unresectable hepatocellular carcinoma
Journal of Cancer Research & Clinical Oncology, 11/24/09

Pancreatic endocrine tumors: Expression profiling evidences a role for AKT-mTOR pathway
Journal of Clinical Oncology, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address